Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study.
Mann JF; Yi QL; Sleight P; Dagenais GR; Gerstein HC; Lonn EM; Bosch J; Clinical Nephrology, 2005, vol. 63, issue 3, p 181, ISSN 03010430. ISBN 03010430.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef